Journal of Addiction Medicine

Article	Citations
Alcohol Consumption in Response to the COVID-19 Pandemic in the United States	181
Opioid Use Disorder and COVID-19: Crashing of the Crises	140
Innovation During COVID-19: Improving Addiction Treatment Access	120
Gambling During the COVID-19 Crisis – A Cause for Concern	88
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report	64
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond	63
The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic: A Longitudinal Study	53
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl	46
Recommended Use of Terminology in Addiction Medicine	42
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)	38
Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study	37
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management	37
Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices?	36
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic	35
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts	34
“Like Yin and Yang”: Perceptions of Methamphetamine Benefits and Consequences Among People Who Use Opioids in Rural Communities	33
The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities	32
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia: Consideration of Problem Gambling and Psychological Distress	32
Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration	31
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report	30
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic	29
Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review	28
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis	28
Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review	25
Early Effects of COVID-19 on Programs Providing Medications for Opioid Use Disorder in Jails and Prisons	25

Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond	24
Hospital-based Buprenorphine Micro-dose Initiation	24
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs	24
Peer Recovery Support Services Across the Continuum: In Community, Hospital, Corrections, and Treatment and Recovery Agency Settings – A Narrative Review	22
Language Matters: It Is Time We Change How We Talk About Addiction and its Treatment	21
The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic - Perspectives of Early Career Professionals in 16 Countries	21
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach	21
Telehealth Capability Among Substance Use Disorder Treatment Facilities in Counties With High Versus Low COVID-19 Social Distancing	20
Medications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection	20
Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder	20
Cannabis-related Hospitalizations Among Youth in Canada Before and After Cannabis Legalization	19
Exercise Addiction Prevalence and Correlates in the Absence of Eating Disorder Symptomology: A Systematic Review and Meta-analysis	19
Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults	19
Shifting Medication Treatment Practices in the COVID-19 Pandemic: A Statewide Survey of Pennsylvania Opioid Treatment Programs	18
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes	18
DEA Disconnect Leads to Buprenorphine Bottlenecks	17
Can Individuals With Alcohol Use Disorder Sustain Non-abstinent Recovery? Non-abstinent Outcomes 10 Years After Alcohol Use Disorder Treatment	17
Barriers to Care Experienced by Patients Who Inject Drugs During the COVID-19 Pandemic: A Qualitative Analysis	17
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey	17
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use	16
Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism	16
Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study	16
Trust in Hospital Physicians Among Patients With Substance Use Disorder Referred to an Addiction Consult Service: A Mixed-methods Study	16
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	16
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia	15
Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic	15
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas	15
Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description	14
Pills to Powder: A 17-Year Transition From Prescription Opioids to Heroin Among US Adolescents Followed Into Adulthood	14
Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes From a Review of State Laws	14
Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication	14
Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge	14
During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio	14
Executive Summary of the American Society of Addiction Medicine (ASAM) Clinical Practice Guideline on Alcohol Withdrawal Management	14
Evaluation of Resident Physicians’ Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder	13
Disparities in Documented Drug Use Disorders Between Transgender and Cisgender U.S. Veterans Health Administration Patients	13
Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations	13
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis	13
COVID-19 and Cannabidiol (CBD)	13
Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis	13
Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis	12
Potential Value of the Insights and Lived Experiences of Addiction Researchers With Addiction	12
Assessing Stigma Towards Substance Use in Pregnancy: A Randomized Study Testing the Impact of Stigmatizing Language and Type of Opioid Use on Attitudes Toward Mothers With Opioid Use Disorder	12
Thematic Analysis of Reddit Content About Buprenorphine-naloxone Using Manual Annotation and Natural Language Processing Techniques	12
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	12
Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada	12
Use of a Telemedicine Bridge Clinic to Engage Patients in Opioid Use Disorder Treatment	12
Differential Gateways, Facilitators, and Barriers to Substance Use Disorder Treatment for Pregnant Women and Mothers: A Scoping Systematic Review	12
Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists	12
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	12

Virtual Twelve Step Meeting Attendance During the COVID-19 Period: A Study of Members of Narcotics Anonymous	11
Inconsistent Addiction Treatment for Patients Undergoing Cardiac Surgery for Injection Drug Use-associated Infective Endocarditis	11
Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	11
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone	11
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies	11
Preferences for Tobacco Cessation Information and Support During Covid-19	11
Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report	11
Changing Outdated Methadone Regulations That Harm Pregnant Patients	11
Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19	11
Suicide Behavior Following PHQ-9 Screening Among Individuals With Substance Use Disorders	11
Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes	10
COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform	10
Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?	10
Geriatric Conditions Among Middle-aged and Older Adults on Methadone Maintenance Treatment: A Pilot Study	10
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	10
Urinary Buprenorphine, Norbuprenorphine and Naloxone Concentrations and Ratios: Review and Potential Clinical Implications	10
Discharges “Against Medical Advice” in Patients With Opioid-related Hospitalizations	10
Alcohol Consumption During the First Year of the COVID-19 Pandemic in the United States: Results From a Nationally Representative Longitudinal Survey	10
Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples	9
Pressure Necrosis Requiring Fasciotomy After Kratom Overdose	9
Civil Commitment for Substance Use Disorders: A National Survey of Addiction Medicine Physicians	9
Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges	9
Calls for Access to Safe Injecting Supplies as a Critical Public Health Measure During the COVID-19 Pandemic	9
Co-occurring Substance Use Disorders Identified Among Delivery Hospitalizations in the United States	9
The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series	8
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine—Case Reports of Expanding Access to Addiction Treatment During COVID-19	8
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	8
Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder	8
Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial	8
Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder	8
Computerized Cognitive Behavioral Therapy for Substance Use Disorders in a Specialized Primary Care Practice: A Randomized Feasibility Trial to Address the RT Component of SBIRT	8
Cannabis Use and Stroke: Does a Risk Exist?	8
Do Sex Differences Among Adults With Opioid Use Disorder Reflect Sex-specific Vulnerabilities? A Study of Behavioral Health Comorbidities, Pain, and Quality of Life	8
Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic	8
Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences	8
Rise in Presence of Methamphetamine in Oral Fluid Toxicology Tests Among Outpatients in a Large Healthcare Setting in the Northeast	8
Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use	8
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	8
Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19	8
Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut	7
False-positive Fentanyl Urine Detection after Initiation of Labetalol Treatment for Hypertension in Pregnancy: A Case Report	7
Skin Necrosis Following Inadvertent Dermal Injection of Extended-release Buprenorphine	7
The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose: A Field Report	7
Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19	7
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	7
A Proposal for Addiction and Infectious Diseases Specialist Collaboration to Improve Care for Patients With Opioid Use Disorder and Injection Drug Use-Associated Infective Endocarditis	7
Substance Use Disorders in Recently Hospitalized Patients With Cirrhosis	7
Evidence on Buprenorphine Dose Limits: A Review	7
Understanding Contraceptive Needs of Women Who Inject Drugs in Orange County: A Qualitative Study	7
2021 Poster Abstracts	7
Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review	7
Gaps in Alcohol Screening and Intervention Practices in Surgical Healthcare: A Qualitative Study	7
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report	6
Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model	6
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	6
Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing	6
In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care	6
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids	6
“Nobody Knows How You’re Supposed to Interpret it:” End-user Perspectives on Prescription Drug Monitoring Program in Massachusetts	6
Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study	6
Utilization of Medications for Opioid Use Disorder Across US States: Relationship to Treatment Availability and Overdose Mortality	6
Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People	6
COVID-19 Social Distancing and Online Mutual Help Engagement for Alcohol Use Recovery	6
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder	6
Opioid-related Emergency Department Visits During COVID-19 in a Large Health System	6
Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis	6
Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment during COVID-19	6
Improving Research on Racial Disparities in Access to Medications to Treat Opioid Use Disorders	6
How Patient Centered Are Addiction Treatment Intake Processes?	6
A Telemedicine Approach to Increase Treatment of Alcohol Use Disorder in Primary Care: A Pilot Feasibility Study	6
Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series	6
Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment	6
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA	6
Prescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone	5
Maternal Cannabis Use in the Perinatal Period: Data From the Pregnancy Risk Assessment Monitoring System Marijuana Supplement, 2016–2018	5
Evaluation of the BEAT Meth Intervention for Emergency Department Patients with Methamphetamine Psychosis	5
Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19	5
Exercise Addiction Stability and Health Effects. A 6-Month Follow-up Postcompetition Study in Amateur Endurance Cyclists	5
Long-Term Effects of Increasing Buprenorphine Treatment Seeking, Duration, and Capacity on Opioid Overdose Fatalities: A Model-based Analysis	5
Opioid Use Behaviors Among People With Disability in the United States: An Analysis of the National Survey on Drug Use and Health	5

Extreme Binge Drinking During Adolescence: Associations With Subsequent Substance Use Disorders in American Indian and Mexican American Young Adults	5
Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications	5
Food Insecurity and Substance Use Among Young Adult College Students in the United States	5
Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic: Providers’ Leadership Efforts in Unprecedented Times	5
Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series	5
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	5
Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later	5
Integrating Reproductive and Sexual Health Education and Services Into Opioid Use Disorder Treatment Programs: A Qualitative Study	5
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 – 2020	5
Medical Student Spirituality and Substance Use	5
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	5
Substance Use and Utilization of Prenatal and Postpartum Care	5
The Naloxone Component of Buprenorphine/Naloxone: Discouraging Misuse, but at What Cost?	5
Factors Associated With Drug Overdoses During the COVID-19 Pandemic	5
Statewide Availability of Buprenorphine/Naloxone in Acute Care Hospitals	5
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting	5
Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment	5